Skip to content

Clinical trials

Phase 1 Diabetes Mellitus, Type 2 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 1 Country / region: China Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20112
20122
20137
20144
201512
20166
20172
20185
20197
20205
202114
202211
20239
202410
202510
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed86
Unknown status17
Recruiting6
Not yet recruiting4
Withdrawn1
Enrolling by invitation1
Terminated1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu HengRui Medicine Co., Ltd.19
Fujian Shengdi Pharmaceutical Co., Ltd.11
Shandong Suncadia Medicine Co., Ltd.8
Novo Nordisk A/S7
Sunshine Lake Pharma Co., Ltd.6
Jiangsu Hansoh Pharmaceutical Co., Ltd.5
Eli Lilly and Company4
Hua Medicine Limited4
Suzhou Yabao Pharmaceutical R&D Co., Ltd.4
AstraZeneca3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2117
Obesity12
Overweight11
Diabetes Mellitus7
Diabetes Mellitus, Type 12
Erectile Dysfunction2
Hyperglycemia2
Weight Loss2
Diabetic Retinopathy1
Fatty Liver1

Trials

Showing 1 to 25 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.